SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : CellularVision (CVUS): 2-way LMDS wireless cable. -- Ignore unavailable to you. Want to Upgrade?


To: Bernard Levy who wrote (1893)4/15/1998 7:21:00 PM
From: James Fink  Respond to of 2063
 
Risk Factors

1. Liquidity Risk; Need for Additional Financing; Risk of Substantial
Dilution.

In the fourth quarter of 1997 and the first quarter of 1998, the
Company experienced a severe liquidity shortfall due to the postponement or cancellation of several planned financing transactions, including a potential syndication of a $40 million senior secured debt facility by Fleet National Bank ("Fleet"), which remains on hold and will be revisited during 1998. In April of 1998, the company entered into several financing arrangements which, while providing the Company with commitments to obtain sufficient funds to continue its operations throughout the 1998 calendar year, provide for, or potentially provide for, the issuance of equity securities at a discount from market prices at the time of funding. Utilization of these sources of financing could, therefore, result in substantial dilution to existing stockholders and, while the Company intends to seek alternative sources of financing on more attractive terms, there can be no assurance that such alternatives will be available prior
to the date that the Company's operations will require additional utilization of these existing, potentially-dilutive financing commitments.

The Company's operations continue to result in negative cash flows, and repayment of existing indebtedness will require additional sources of liquidity in the future. Therefore, the Company anticipates that its future financing requirements will continue to be substantial. The Company intends to address those requirements through a combination of strategic and financial investments, but there can be no assurance that the Company will be successful in implementing the necessary financing arrangements on favorable terms. The lack
of availability of additional capital could have a material adverse effect on the Company's financial condition, operating results and prospects for growth.


2. Loss of Key Personnel.

Successful implementation of the Company's business plan will require the management of growth, which will require the continued implementation and improvement of the Company's operating
and financial systems and controls. There can be no assurance that the systems or controls currently in place or to be implemented will be adequate to manage such growth, or that any steps taken to improve such systems and controls will be sufficient. The Company's success also depends in part upon attracting and retaining the services of its management and technical personnel. The competition for qualified personnel is intense. The Company recently suffered the untimely loss of its President to a sudden illness, and has also recently witnessed the departure of a key marketing officer and a key financial officer.
Although the duties of these individuals have been assumed by other corporate officers, the Company believes that it would be advisable to bolster its management ranks, although it recognizes that its present financial situation will make recruitment of additional qualified personnel more difficult. There can be no assurance that the Company will be able to retain its existing key managerial and technical employees, or that it will be able to attract, assimilate or retain other skilled managerial and technical personnel in the
future. The Company does not maintain "key person" life insurance policies on any of its key personnel.

3. Potential Conflicts of Interest; Dependence on Technology Licensed from CT&T.

Shant S. Hovnanian, the Chairman of the Board of Directors, President and Chief Executive Officer of the Company, Bernard B. Bossard, Executive Vice President, Chief Technical Officer and a Director of the Company, and Vahak S. Hovnanian, a Director of the Company, (collectively, the "Founders") are 80% controlling owners of CT&T. Philips, one of the three original corporate investors (together with an affiliate of Bell Atlantic and an affiliate of J.P. Morgan, the "Corporate Investors") in the Company, owns the remaining 20% of CT&T. Mr. Bossard is permitted under the terms of his employment agreement with the Company to devote a portion of his business time to other entities, including CT&T, so long as he devotes such substantial portion of his working time and efforts to the Company's affairs as the Company's Board of Directors may reasonably require. Shant Hovnanian also may devote a portion of his business time to CT&T and other related entities. Although his employment agreement with the Company provides that he will devote substantially all of his working time and efforts to the Company's affairs, pursuant to the agreement, Mr. Hovnanian may devote such working time and efforts to CT&T and its affiliates as the due and faithful performance of his obligations under the agreement permits. CT&T and these individuals are parties to a number of agreements with the Company, including the CT&T License Agreement and a reserved channel rights agreement, which may from time to time present conflicts of
interest with the Company.

In serving in their respective positions with the Company, the Founders may experience conflicts of interest involving the Company and CT&T. As owner of the name and mark "CellularVision," CT&T has the right to license the name and mark "CellularVision," as well as the associated know-how and trade secrets, to related or unrelated entities providing services similar to those provided by the Company outside the New York BTA, for which it may receive a fee. The
Company may in the future be dependent upon CT&T's ability to enhance its current technology and to respond to emerging industry standards and other technological changes.

Bell Atlantic has the right to designate one member of the Board of Directors (the "Bell Atlantic Nominee"). To date, Bell Atlantic has not exercised this right. Bell Atlantic currently provides Internet access service in the New York metro area and is allowed, under the provisions of the Telecommunications Reform Act, to provide video services which could compete with video services offered by the Company.


4. Control by Principal Stockholders.

The Founders in the aggregate own approximately 62.4% of the outstanding Common Stock. As a result, such stockholders will have the power to elect all of the members of the Company's Board of Directors, amend the Company's Certificate of Incorporation and By-Laws and, subject to certain limitations imposed by applicable law, effect or preclude fundamental corporate transactions involving the Company, including the acceptance or rejection of any proposals relating to a merger of the Company or an acquisition of the Company by another entity, in each case without the approval of any of the Company's other stockholders. The Founders are parties to
a Stockholders' Agreement, dated as of January 12, 1996 (the "Stockholders' Agreement"), which provides that the parties thereto, who collectively owned 69.2% of the shares of Common Stock outstanding upon the consummation of the Initial Public Offering, will vote to elect each of the Founders to the Company's Board of Directors, so long as such Founder owns 5% or more of the shares of Common Stock outstanding on a fully diluted basis. Bell Atlantic has
the right to appoint the Bell Atlantic Nominee to the Company's Board of Directors, so long as Bell Atlantic shall hold at least 1% of the shares of Common Stock outstanding on a fully diluted basis. The parties to the Stockholders' Agreement have also agreed not to vote to remove any Founder or the Bell Atlantic Nominee so elected except for "cause."



To: Bernard Levy who wrote (1893)4/15/1998 7:35:00 PM
From: James Fink  Read Replies (1) | Respond to of 2063
 
The dilution looks pretty substantial. J.P. Morgan gets 27,000 shares at one cent per share. Newstart/Logimetrics gets 100,000 shares at one cent per share. CS First Boston affiliate gets to purchase $10 million worth of CVUS stock at 12 percent discount. Marion Interglobal gets 110,000 shares for "nominal consideration" and the right to purchase $2 million worth of CVUS stock for the lesser of 20 percent discount or $3.20 per share, with a floor of $1.60. See below:

On January 21, 1998, the Company issued new Subordinated Exchange Notes, in the aggregate principal amount of $1,191,147 (the "New Notes"), to the holders (the "Holders") of the Company's Subordinated Exchange Notes (the "Original Notes") held by an affiliate of J.P. Morgan, in exchange for $1 million in cash and as payment of $191,147 in respect of an interest payment due
on December 28, 1997. Also, in connection with the issuance of the New Notes, the Holders waived certain defaults under the Original Notes. As consideration for the purchase of the New Notes and the waiver of certain defaults under the Original Notes, the Holders received a warrant to purchase 27,000 shares of the Company's Common Stock at an exercise price of $0.01 per share.

On April 1, 1998, the Company entered into separate financing agreements with Proprietary Convertible Investment Group, Inc. ("Proprietary"), which is an affiliate of CS First Boston, and Marion Interglobal Ltd. ("Marion"). Pursuant to a Securities Purchase Agreement, dated April 1, 1998, between the Company and Proprietary (the "Proprietary Purchase Agreement"), on April 6,
1998 the Company issued 3,500 shares of its Series A Convertible Preferred Stock ("Convertible Preferred Stock") to Proprietary for $3.5 million. Subject to certain conditions, including the registration under the Securities Act of the underlying shares of Common Stock, the Proprietary Purchase Agreement provides for the issuance, at the Company's option, of an additional 3,500 shares of Convertible Preferred Stock at a purchase price of $1,000 per share at any time
on or after June 15, 1998 and prior to December 31, 1998. The Proprietary Purchase Agreement also provides for the issuance, at Proprietary's option, of an additional 3,000 shares of Convertible Preferred Stock at a purchase price of $1,000 per share during the three year period following April 6, 1998. The Convertible Preferred Stock has a dividend rate of 4%, which may be paid in cash
or, at the option of the Company and subject to certain conditions, in stock. The Convertible Preferred Stock may be converted into Common Stock of the Company at any time at the option of the holder thereof at an initial conversion price of $5.25 for the ninety day period following April 6, 1998. Following such ninety-day period, or in the event that certain conditions are not satisfied during such ninety-day period, the conversion price shall be the lesser of (i) $5.25 and (ii) 88% of the lesser of (A) the average of the lowest sale prices for the Common Stock on each of any three trading days during the twenty two trading days occurring immediately prior to (but not including) the applicable conversion date and (B) the average of the three lowest closing bid prices for the Common Stock during the twenty two trading days occurring immediately prior to (but not including) the applicable conversion date. In addition, the Company has the right to redeem all the Convertible Preferred Stock outstanding in the event that the closing bid price for the Common Stock is above $10 for twenty two consecutive trading days at a price equal to 130% of (i) the stated value of the Convertible Preferred Stock ($1,000 per share) plus (ii) accrued and unpaid dividends thereon. The Convertible Preferred Stock is subject to mandatory redemption upon the occurrence of certain events of default. In addition, the Proprietary Purchase Agreement contains certain capital raising limitations which could preclude certain equity-linked financing transactions in excess of
$6 million for a period of one year following the final issuance of Convertible Preferred Stock under the agreement.

Pursuant to a Securities Purchase Agreement, dated April 1, 1998, between the Company and Marion (the "Marion Purchase Agreement"), on April 6, 1998, the Company issued to Marion (i) a Warrant to purchase up to $2 million worth of shares of Common Stock (the "Warrant Shares") and (ii) 110,000 shares of its Common Stock. The shares of Common Stock were issued for nominal consideration and the Warrant is exercisable (the "Exercisability Date") from and after the earlier to occur of (i) the date on which there is an effective registration statement under the Securities Act of 1933, as amended, relating to the resale of the Warrant Shares and (ii) June 28, 1998. The Company has the right to cause Marion to exercise the Warrant following the Exercisability Date. The exercise price per share of Common Stock is the lesser of (i) 80% of the average closing
price of the Common Stock on the five trading days preceding the issuance of such Common Stock and (ii) $3.20 per share, provided that such price will in no event be less than $1.60 per share. The Company has the right to cancel the Warrant at any time prior to the Exercisability Date. In the event that the Company elects to cancel the aforementioned warrant, the Company does not currently have capital available to make the scheduled June 30, 1998 payments to
the Holders of the Original Notes and the New Notes without raising additional capital for this purpose.

Pursuant to a Letter Agreement, dated April 1, 1998, among the Company, CVNY and Newstart (the "Newstart Agreement"), the parties agreed to restructure the terms of CVNY's Secured Promissory Note (the "Original Note") on the following terms: (i) the Company paid Newstart $500,000 from the proceeds of the initial sale of Preferred Stock pursuant to the Proprietary Purchase Agreement, (ii) the Original Note was amended and restated as a Secured Convertible Promissory Note in the principal amount of $2,315,917 (the "New Note") and (iii) the Company issued to Newstart a warrant to purchase 125,000 shares of the Company's Common Stock at an exercise price of $5.00 per share of Common Stock. The New Note provides that CVNY will pay an additional $500,000 on or before the earlier to occur of (i) the consummation by the Company of a financing transaction yielding gross proceeds to the Company in excess of $2.5 million and (ii) ninety days following April 1, 1998. In addition, CVNY has the right to prepay the New Note in full at any time prior to October 1, 1998 at a price equal to 125% of the outstanding principal amount. At the option of the holder, the New Note may be converted in whole or in part at any time and from time to time at a conversion price per share equal to 91% of the average of the lowest trading price on each of the four trading days immediately prior to the conversion notice, provided, however, that the holder may not convert more than $500,000 in principal amount of the New Note in any calendar month. In the event that Newstart has not exercised their option to convert the New Note by April 1, 1999, the Company is obligated to pay the remaining balance, including accrued interest. The New Note is subject to acceleration upon the occurrence of certain events of default.

To effectuate the restructuring contemplated by the Newstart Agreement, the Company and CVNY entered into an Agreement, dated April 1, 1998, with the holders of the Company's Subordinated Exchange Notes (the "Subordinated Exchange Notes Agreement") pursuant to which such holders consented to such restructuring. In consideration for such consent, the Company granted such holders warrants to purchase 100,000 shares of the Company's Common Stock at an exercise price of $.01 per share of Common Stock.